Study of LED Phototherapy for Musculoligamentous Lesions

December 5, 2008 updated by: Hermano Miguel Foundation
The purpose of this study is to determine whether LED phototherapy using combined red and near infrared light (approved: Ministry of Health of Russian Federation No. 29/06070997/1080-00, EUROCAT Certificate No. CP033321-IV) is effective in the treatment of musculoligamentous lesions in physiotherapy practice

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Ecuador
    • Pichincha
      • Quito, Pichincha, Ecuador
        • CAID, Hermano Miguel Foundation
      • Quito, Pichincha, Ecuador
        • Health Service, UDV Quito Centro Occidente, National Police of Ecuador
      • Quito, Pichincha, Ecuador
        • Rehabilitation Department, A.B.E.I. Foundation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinical diagnosis of acute or chronic musculoligamentous lesion
  • Must be able to understand instructions and fill in auto administered questionnaires
  • Informed consent

Exclusion Criteria:

  • Use of oral corticosteroids or corticosteroid injections
  • Systemic diseases
  • General contraindications for phototherapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hermano Miguel Foundation

Investigators

  • Principal Investigator: Sergiy Voznesenskyy, PhD, BPT, Hermano Miguel Foundation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted

September 29, 2006

First Submitted That Met QC Criteria

September 29, 2006

First Posted (ESTIMATE)

October 2, 2006

Study Record Updates

Last Update Posted (ESTIMATE)

December 8, 2008

Last Update Submitted That Met QC Criteria

December 5, 2008

Last Verified

December 1, 2008

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FT-01-05-05

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe